BeOne Medicines Ltd. (ONC): Operating Income
$447.14M
Year ended 2025-12-31
$923.10M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $447.14M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$568.20M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$1.21B | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$1.79B | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$1.44B | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$1.66B | n/m | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | -$959.89M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$705.77M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$98.46M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$117.06M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$56.74M | n/m | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | -$15.76M | n/a | 2017-03-22, From 2014-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $447.14M | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$430.24M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.12B | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $501.58M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $409.48M | -15.4% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.49B | +8.4% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $394.10M | +58.1% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.81B | +17.3% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $4.17B | n/m |
Compare ONC, JAZZ, PRGO, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗